Advanced Oncotherapy PLC (LON:AVO)

Advanced Oncotherapy PLC (LON:AVO)


Share Price
39.00 p
Change
0.5 (1.30 %)
Market Cap
£78.17 m
Proactive Investors - Run By Investors For Investors

Advanced Oncotherapy PLC

www.avoplc.com

Overview

Figures in £(m) unless stated
Sales 0.000
EBITDA -21.375
Operating Profit -21.800
Pre-tax Profit -21.866
Net Profit -21.107
Capex -12.093
Operating Cash Flow -1.665
Net Working Capital 4.723
Key Ratios
EBITDA Margin 0.000
Operating Profit Margin 0.000 -%
Net Profit Margin 0.000 -%
Capex/Sales (%) 0.000
NWC/Sales (%) -
Asset Turnover 0.000
Days Inventory 1686.770  days
Days Receivable 0.000  days
Days Payable 650.851  days
Performance (Last 3 Years)
Sales CAGR 0.000
EBITDA CAGR n/a
Operating Profit CAGR -
Profit CAGR -
Return on Equity(%) -67.510
Return on Assets(%) -40.343
Return on Invested Capital (ROIC)(%) -56.300
ROIC - WACC n/a
Valuation
Market Cap -
Price to Earnings 0.000
Price to Book Value 2.299
Price to Tangible Book -
Equity to FCF Yield -185.5579868709
Enterprise Value -
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield -
Payout Ratio 0
Per Share Data (in GBp unless stated)
Earnings per share -0.140200
Operating Cashflow per share -0.01105938542068
Free Cashflow per share -0.091400
Dividend per share -
NAV per share -
Cash per share -0.011100
Solvency
Intangibles Incl. Excl.
Net debt to Equity % 5.8447355045443 -32.205578537513
Cash to Equity % 2.9799621414588 -4016507297.02
Gross debt to Equity % 8.8246976460031 -48.625723591288
Gross Debt < 1 Year to Equity 8.8246976460031 -48.625723591288
Net debt to Assets % 5.0462340165794 15.555968768178
Net Debt/EBITDA -9.2956406492975 -0
Net Interest Cover -271.692107 n/a
Op Cashflow Interest Cover -20.762742090364 n/a
Current Ratio 1.527408 n/a
Quick Ratio 0.177539 n/a
Cash Ratio - n/a (Intangibles collected as non-current)
Dividend Cover - n/a
Key Dates
Latest Dividend Pay date n/a
Latest Ex-Dividend date n/a
Last Annual Results 2019-06-28
Last Interim Results 2019-06-28

Profit/Loss

Figures in £(m) unless stated31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
Sales 0.0000.0000.0000.0000.1060.0690.1006.161
Cost of Goods Sold 1.9090.0000.0000.0000.2030.1560.0015.208
Gross Profit -1.9090.0000.0000.000-0.096-0.0870.0990.953
Operating Expenses 19.89114.49313.0877.6185.5542.0371.1591.570
EBITDA -21.375-14.848-12.733-8.444-5.836-3.091-1.561-0.928
Depreciation & Amortisation --0.0000.8870.8031.049-0.300
EBIT (Operating Profit) -21.800-14.493-13.087-7.618-5.650-2.124-1.060-0.617
Interest Expense/Income 0.0671.2740.0970.1240.3770.2580.319-
Profit Before Tax -21.866-16.487-13.185-8.629-6.331-3.431-1.884-1.669
Taxes on Income -0.759-2.827-2.818-2.7840.0000.0000.000-0.288
Net Profit -21.107-13.660-10.367-5.845-6.331-3.431-1.884-1.381
Net Margin -----70.158-57.117-27.136-1.092
Net profit/loss per share
Basic EPS -0.140-0.176-0.171-0.115-0.188-0.215-0.268-0.450
Diluted EPS -0.140-0.176-0.171-0.115-0.188-0.215-0.268-0.450

Balance sheet

 
Figures in £(m) unless stated 31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
ASSETS         
Tangible Assets --------
Intangible Assets 40.16530.57023.35512.7449.2186.6900.0000.000
Investments --------
Total Fixed Assets 45.77332.90025.12914.05611.2979.3694.1275.611
Stocks 10.0147.6297.4384.4181.1120.037--
Debtors --0.0000.0030.0740.0290.0030.005
Cash & Equivalents --------
Total Current Assets 13.67812.50112.54116.6823.1691.3831.5101.463
Other Assets n/a         
Total Assets 59.45045.40037.67030.73914.46610.7525.6377.074
LIABILITIES         
Interest bearing debt < 1 year 3.0009.2470.5431.0000.9883.1903.8043.802
Other Trade Creditors < 1 year --------
Total Creditors within 1 year 8.95516.7393.6783.4593.3345.3865.7766.596
Interest bearing debt > 1 year -0.0000.000---0.000-
Other Trade Creditors > 1 year --------
Total Creditors > 1 year 0.0000.0000.0000.0000.0000.0000.0000.000
Other Liabilities  n/a         
Total Liabilities 25.45516.7393.6783.4593.3345.3865.7766.596
Net Assets(NET Tangible Assets exist) -6.170-1.90810.63814.5361.914-1.325-0.1390.478
EQUITY         
Called up share capital 42.39220.23418.11714.18310.2846.0442.5940.765
Share Premium 50.72443.25943.11832.81514.6596.8741.6661.398
Profit / loss -78.809-57.724-44.064-33.719-27.164-19.601-15.631-12.894
Other Equity 19.68922.89316.82214.00113.35212.04811.23111.209
Shareholders Funds 33.99528.66233.99327.28011.1325.365-0.1390.478
Preference Stock --------
Total Capital Employed 33.99528.66233.99327.28011.1325.365-0.1390.478

Cash flow

Figures in £(m) unless stated 31/12/1831/12/1731/12/1631/12/1531/12/1431/12/1331/12/1231/12/11
EBITDA -21.107-13.660-10.367-5.845-6.331-3.970-1.884-0.972
Change in Working Capital -6.0541.171-2.342-5.758-0.812-0.077-0.5071.083
Cash Taxes Paid --------
Cash Interest Paid/Received --------
Other (incl. non-cash items) -0.080-0.569-0.247-0.148-0.178-0.331-0.070-0.464
Net Cash from Operating Activities -1.665-9.585-10.930-9.845-6.558-2.938-1.377-0.254
Capital Expenditure -12.093-8.561-9.679-4.288-1.311-0.732-0.191-0.334
Acquisitions/Disposals --------
Other Investing Activities --------
Net Cashflow from Investing Activities -12.080-8.561-9.662-3.725-1.3050.540-0.682-0.334
Dividends --------
Increase/Decrease in Debt -5.74716.504-0.4570.000-0.9780.0521.1270.391
Increase/Decrease in Equity 21.0530.25013.53921.06310.1582.4371.319-
Other Financing Activities -0.6500.0000.0000.0000.0000.0000.000-
Cash from Financing 14.65516.75413.08221.0639.1802.4892.4460.391
Net increase in cash 0.911-1.392-7.5107.4931.3160.0910.387-0.197

Directors dealings

Date Director Trans Amount Type Price(p) Value (£) Holding %
- Dr. Michael Jeffrey Sinclair - - Incentives - - 1977000.00
- Nicolas Serandour - - Incentives - - 2200000.00
- Professor Stephen Myers OBE - - Incentives - - 215000.00
- Dr. Michael Jeffrey Sinclair - - Ords - - 6594660.00 3.3894190
- Dr Enrico Cipro Vanni - - Ords - - 1926361.00 0.9900805
- Mr. Michael Bradfield - - Ords - - 7080740.00 3.6392467
- Mr. Gabriel Urwitz - - Ords - - 6488789.00 3.3350051
- Dr. Piers Nicholas Plowman - - Ords - - 3930304.00 2.0200354
- Nicolas Serandour - - Ords - - 1760467.00 0.9048170
- Professor Stephen Myers OBE - - Ords - - 783902.00 0.4028975
- Mr. Hans Henrik von Celsing - - Ords - - 30000.00 0.0154189
2018-08-31 Dr Enrico Cipro Vanni P 204082.00 ORD 25P 49 100000 1926361.00 1.1360532
2018-08-31 Dr. Piers Nicholas Plowman P 306122.00 ORD 25P 49 150000 4084354.00 2.4087092
2018-08-31 Mr. Hans Henrik von Celsing P 30000.00 ORD 25P 49 14700 30000.00 0.0176922
- Dr. Michael Jeffrey Sinclair - - ORD 25P - - 4928229.00 2.9063765
- Mr. Michael Bradfield - - ORD 25P - - 7080740.00 4.1757995
- Dr. Piers Nicholas Plowman - - ORD 25P - - 3470132.00 2.2176310
- Professor Christopher Nutting - - ORD 25P - - 217316.00 0.1396370
- Professor Christopher Nutting - - ORD 25P - - 217316.00 0.1281601
- Mr. Sanjeev Pandya - - ORD 25P - - 58616.00 0.0376639
- Mr. Sanjeev Pandya - - ORD 25P - - 58616.00 0.0345682
- Nicolas Serandour - - ORD 25P - - 93800.00 0.0553177
- Professor Stephen Myers OBE - - ORD 25P - - 450569.00 0.2657188
- Dr. Euan Stuart Thomson PhD - - Incentives - - 200000.00
- Dr. Michael Jeffrey Sinclair - - Incentives - - 1432000.00
- Dr Enrico Cipro Vanni - - Incentives - - 200000.00
- Mr. Michael Bradfield - - Incentives - - 1600000.00
- Professor Christopher Nutting - - Incentives - - 300000.00
- Mr. Sanjeev Pandya - - Incentives - - 1800000.00
- Nicolas Serandour - - Incentives - - 800000.00
- Mr. Hans Henrik von Celsing - - Incentives - - 200000.00
2018-01-11 Dr Enrico Cipro Vanni P 40000.00 ORD 25P 54.5 21800 1263946.00 0.8077404
2017-07-31 Dr Enrico Cipro Vanni P 100000.00 ORD 25P 17.75 17750 1223946.00 1.5122544
- Mr. Michael Bradfield - - ORD 25P - - 7080740.00 4.5497493
- Mr. Sanjeev Pandya - - ORD 25P - - 58616.00 0.0376639
- Nicolas Serandour - - ORD 25P - - 93800.00 0.0602715
- Dr. Euan Stuart Thomson PhD - - Incentives - - 200000.00
- Dr. Michael Jeffrey Sinclair - - Incentives - - 1432000.00
- Mr. Timothy Andrew Lebus - - Incentives - - 300000.00
- Dr Enrico Cipro Vanni - - Incentives - - 200000.00
- Mr. Michael Bradfield - - Incentives - - 1600000.00
- Professor Christopher Nutting - - Incentives - - 7500000.00
- Mr. Sanjeev Pandya - - Incentives - - 1800000.00
- Nicolas Serandour - - Incentives - - 800000.00
2017-05-15 Professor Stephen Myers OBE P 400000.00 ORD 25P 26 104000 450569.00 0.2895144
2017-05-08 Professor Christopher Nutting P 202500.00 ORD 25P 24.67 49957 217316.00 0.1396370
2017-05-12 Dr. Piers Nicholas Plowman P 833333.00 ORD 25P 30 250000 3470132.00 2.2297430
2017-04-25 Dr. Michael Jeffrey Sinclair P 200000.00 ORD 25P 30.44 60880 4928229.00 3.1666474
2017-04-24 Dr Enrico Cipro Vanni P 100000.00 ORD 25P 26.96 26960 1123946.00 1.3886987
2017-04-12 Dr Enrico Cipro Vanni P 100000.00 ORD 25P 27.5 27500 1023946.00 1.3807964
2017-04-03 Dr. Michael Jeffrey Sinclair P 100000.00 ORD 25P 28.35 28350 4728230.00 6.3760424
2017-04-03 Dr Enrico Cipro Vanni P 75000.00 ORD 25P 28.67 21503 898946.00 1.2369960
2017-04-04 Dr Enrico Cipro Vanni P 25000.00 ORD 25P 29.25 7313 923946.00 1.2653934
- Dr. Piers Nicholas Plowman - - ORD 25P - - 2636799.00 3.5179900
- Mr. Timothy Andrew Lebus - - 1p Ords - - 54520.00 0.0960191
- Professor Stephen Myers OBE - - ORD 25P - - 50569.00 0.0667268
2017-01-03 Dr Enrico Cipro Vanni P 25000.00 ORD 25P 87 21750 798946.00 1.0993909
2016-12-22 Dr Enrico Cipro Vanni P 25000.00 ORD 25P 59.75 14938 773946.00 1.0676253
2016-12-20 Dr Enrico Cipro Vanni P 25000.00 ORD 25P 56 14000 698946.00 0.9641660
2016-11-28 Dr Enrico Cipro Vanni P 75000.00 ORD 25P 64.7 48525 673946.00 0.9296796
2016-11-11 Dr Enrico Cipro Vanni P 36946.00 ORD 25P 101.5 37500 598946.00 0.8262203
2016-09-16 Lord David Evans of Watford S 136296.00 ORD 25P 121 164918 56001.00 0.0330261
2016-10-07 Dr. Michael Jeffrey Sinclair P 1035000.00 ORD 25P 100 1035000 4628230.00 6.3686829
2016-10-07 Mr. Michael Bradfield P 2000000.00 ORD 25P 100 2000000 7080740.00 8.7486539
2016-10-07 Mr. Sanjeev Pandya P 35000.00 ORD 25P 100 35000 58616.00 0.0724234
2016-10-07 Nicolas Serandour P 85000.00 ORD 25P 100 85000 93800.00 0.1158952
2016-07-11 Mr. Michael Bradfield P 30000.00 ORD 25P 135 40500 5080740.00 7.0086628
2016-07-08 Mr. Michael Bradfield P 10000.00 ORD 25P 119.5 11950 5050740.00 8.8952235
2016-07-06 Mr. Michael Bradfield P 50000.00 ORD 25P 102.5 51250 5030740.00 8.8600000
2016-07-06 Mr. Michael Bradfield P 10000.00 ORD 25P 112 11200 5040740.00 8.8776118
- Dr. Michael Jeffrey Sinclair - - 1p Ords - - 3593230.00 6.3282977
- Lord David Evans of Watford - - 1p Ords - - 192297.00 0.3386676
- Mr. Timothy Andrew Lebus - - 1p Ords - - 54520.00 0.0960191
- Dr Enrico Cipro Vanni - - 1p Ords - - 562000.00 0.9897788
- Mr. Michael Bradfield - - 1p Ords - - 4980740.00 8.7719420
- Professor Christopher Nutting - - 1p Ords - - 14816.00 0.0260935
- Mr. Sanjeev Pandya - - 1p Ords - - 23616.00 0.0415918
- Nicolas Serandour - - 1p Ords - - 8800.00 0.0154983
- Dr. Sanjeev Kanoria - - 1p Ords - - 4444440.00 0.3130970
- Dr. Michael Jeffrey Sinclair - - 1p Ords - - 89830758.00 6.3282977
- Lord David Evans of Watford - - 1p Ords - - 4807417.00 0.3386676
- Mr. Timothy Andrew Lebus - - 1p Ords - - 1363000.00 0.0960191
- Dr Enrico Cipro Vanni - - 1p Ords - - 14050000.00 0.9897788
- Mr. Michael Bradfield - - 1p Ords - - 124518510.00 8.7719420
- Professor Christopher Nutting - - 1p Ords - - 370400.00 0.0260935
- Mr. Sanjeev Pandya - - 1p Ords - - 590400.00 0.0415918
- Nicolas Serandour - - 1p Ords - - 220000.00 0.0154983
- Dr. Sanjeev Kanoria - - 1p Ords - - 4444440.00 0.3130970
- Dr. Euan Stuart Thomson PhD - - Incentives - - 5000000.00
- Dr. Michael Jeffrey Sinclair - - Incentives - - 65800000.00
- Lord David Evans of Watford - - Incentives - - 10000000.00
- Mr. Timothy Andrew Lebus - - Incentives - - 7500000.00
- Dr Enrico Cipro Vanni - - Incentives - - 5000000.00
- Mr. Michael Bradfield - - Incentives - - 40000000.00
- Professor Christopher Nutting - - Incentives - - 7500000.00
- Mr. Sanjeev Pandya - - Incentives - - 45000000.00
- Nicolas Serandour - - Incentives - - 20000000.00

Dividends

Temporarily not available. Please try again later.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use